Exxon Mobil Corporation (NYSE:XOM) Analyzing Financial Health

Mae Love
November 13, 2017

Avid Technology had 5 analyst reports since August 11, 2015 according to SRatingsIntel. H.C. Wainwright initiated the stock with "Buy" rating in Wednesday, August 19 report. The stock has "Underweight" rating by Jefferies on Monday, July 11. Piper Jaffray has "Buy" rating and $3.0 target. HSBC set a $88.50 price target on Exxon Mobil Corp. and gave the company a "neutral" rating in a research note on Wednesday, July 13th. As per Tuesday, August 30, the company rating was maintained by Oppenheimer. (NASDAQ:AVID) rating on Thursday, November 10.

Mason Street Advisors Llc increased Exxon Mobil Corp (XOM) stake by 2.63% reported in 2017Q2 SEC filing. The Bragg Financial Advisors Inc holds 90,640 shares with $7.33M value, down from 97,780 last quarter.

Exxon Mobil Corporation is an energy company.

The SMA200 of the stock is at 1.98%, SMA20 is -0.44%, while SMA50 is 1.70%. Almost 8.69 million shares were traded by the close, lower than its average daily volume of 9.38 million shares. It has underperformed by 25.78% the S&P500.

Investors sentiment decreased to 0.85 in 2017 Q2. Its down 0.04, from 0.89 in 2017Q1.

Exxon Mobil Corporation (NYSE:XOM) ended its day at $82.94 with the rising stream of -1.23% and its total traded volume was 8.69 million shares less than the average volume. 36 funds opened positions while 97 raised stakes. Analysts have placed a $83.93 price target on Exxon Mobil Corporation, suggesting a 1.19% gain from recent close. Patten Group Inc holds 1.16% or 35,801 shares.

Michael Bublé announces fully seated Croke Park concert for next summer
It's the first summer 2018 gig announced for Croker and "the undisputed king of cool's" only show in Ireland for the year. It's the news many fans have been waiting for, the Canadian crooner will play Croke Park on Saturday July 7, 2018.

Bill Gates announces major donation to advance the fight against Alzheimer's
Microsoft co-founder Bill Gates announced Monday that he is investing $50 million to fund research into treatment for Alzheimer's disease.

Union Government set to launch BharatNet phase 2 project
DoT will also sign Memorandum of Understanding with States for the implementation of BharatNet Phase II during the Conference. Phase 1 of the project, under which 100k Gram Panchayats were to be connected, will be completed by the end of this year.

Relative strength index (RSI-14) for Exxon Mobil Corporation (XOM) is at 50.78. Lenox Wealth Mgmt Inc has 0.07% invested in Exxon Mobil Corporation (NYSE:XOM) for 2,186 shares. Fmr Ltd Limited Liability Company reported 182,377 shares. Yhb Investment holds 126,091 shares. Williams Jones And Ltd Liability Corp holds 0.74% or 365,441 shares. Finally, Sequent Asset Management LLC increased its position in shares of Exxon Mobil Corp.by 25.9% in the second quarter. Mitsubishi Ufj Securities stated it has 1,900 shares or 0.82% of all its holdings. First Citizens State Bank & Tru reported 150,735 shares.

Exxon Mobil Corporation (XOM)'s distance from 200 day simple moving average is 1.98 percent, its distance from 50 day simple moving average is 1.7 percent, while its distance from 20 day simple moving average is -0.44 percent. Jefferies Group reiterated a "hold" rating on shares of Exxon Mobil Corp.in a research note on Sunday, July 10th. Therefore 100% are positive. Currently, Exxon Mobil Corporation net profit margin for the 12 months is at 5.5%. On Tuesday, April 11 the stock rating was maintained by BMO Capital Markets with "Outperform". Jefferies maintained the stock with "Hold" rating in Friday, June 23 report.

In other Exxon Mobil Corporation news, VP Robert Stuart Franklin sold 22,656 shares of the firm's stock in a transaction that occurred on Monday, September 18th. The firm has "Overweight" rating given on Tuesday, October 10 by Barclays Capital. Wall Street is only getting more bearish on the stock, with 6 of analysts who cover XOM having a buy-equivalent rating. The firm has "Underperform" rating by Raymond James given on Wednesday, November 18. On Thursday, July 6 the stock rating was reinitiated by RBC Capital Markets with "Buy". Innoviva, Inc. (INVA) has a Return on Assets of 26.40%. The company has market cap of $57.34 million. The Firm develops and makes pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The Company's subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors.

Investors sentiment increased to 1.12 in 2017 Q2. Its down 0.01, from 1.29 in 2017Q1. It fall, as 16 investors sold Antares Pharma Inc shares while 14 reduced holdings. The stock climbed 6.02 percent over the past quarter, while surged 0.17 percent over the past six months. Hartwell J M Partnership reported 75,043 shares. Thompson Davis Communication reported 1% in Antares Pharma Inc (NASDAQ:ATRS). Westpac Banking accumulated 112,676 shares. Huntington Bancshares has 0% invested in Zayo Group Holdings Inc (NYSE:ZAYO) for 431 shares. Natl Planning has invested 0.01% in Antares Pharma Inc (NASDAQ:ATRS). About shares traded. Casey's General Stores Inc (NASDAQ:CASY) has risen 0.79% since November 13, 2016 and is uptrending. Nomura Asset Mgmt reported 21,000 shares. Weatherstone Capital owns 9,963 shares or 0.53% of their United States portfolio. Finally, Cowen and Company reissued a "buy" rating and issued a $100.00 target price on shares of Exxon Mobil Corporation in a research report on Tuesday, September 19th. Citadel Advsrs Ltd Co reported 0% stake. Shufro Rose & reported 289,005 shares stake. Menta Cap Limited Liability stated it has 92,200 shares. Beese Fulmer, Ohio-based fund reported 109,997 shares. Citigroup accumulated 947 shares.

Since June 2, 2017, it had 2 insider buys, and 1 insider sale for $1.34 million activity. On Friday, June 9 Powell Fred M bought $363,272 worth of Antares Pharma Inc (NASDAQ:ATRS) or 130,000 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by

Discuss This Article